An enzyme-linked immunosorbent assay was used to evaluate the immunoglobulin G (IgG) response to Staphylococcus aureus crude teichoic acid (TA) and peptidoglycan (PG) in both rabbits and patients with osteomyelitis. In rabbits with experimental S. aureus osteomyelitis, elevated levels of IgG to TA were present in 13/18 (72%) of the serum samples obtained at 4 and 10 weeks postinfection. In contrast, only 5/18 (28%) of these sera were found to be positive for antibodies to PG. Of a total of 39 patients with confirmed S. aureus osteomyelitis (11 acute, 28 chronic), IgG to TA was elevated in 17 (44%), whereas antibodies to PG were found to be increased in only 1 (3%). Cross-reacting antibodies to S. aureus TA were detected in only 1/18 (6%) of the patients with osteomyelitis caused by organisms other than S. aureus. These studies indicate that IgG to TA is more prevalent than IgG to PG in patients with staphylococcal osteomyelitis. Although these results are encouraging, a larger number of patients is required for an adequate evaluation of the TA enzyme-linked immunosorbent assay for the diagnosis and management of suspected S. aureus osteomyelitis.
Osteomyelitis, secondary to trauma, surgical prosthesis implantation, or a contiguous focus of infection, is common and may cause serious permanent disability (9) . Despite the use of agressive antibiotic therapy, acute osteomyelitis is difficult to treat and progresses to the chronic stage in approximately 15 to 30% of patients (16) . Staphylococcus aureus is the most common etiological agent of osteomyelitis and is isolated in about 60% of all cases (29) . Although the diagnosis of osteomyelitis is readily established in the presence of clinical and radiographic evidence of osseous infection, identification of the etiological agent by bacteriological cultures is often difficult. In some patients with acute osteomyelitis, blood cultures may be negative; cultures of bacteria from open wounds or draining sinus tracts are often unreliable because the organisms isolated may represent only superficial contaminants rather than the actual etiological agents of the bone infection (34) . Moreover, it has been estimated that a specific bacterial etiology can be isolated in only 50 to 70% of cases (19) .
Because of the difficulties associated with the isolation of the causative agent of osseous infections by routine bacteriological techniques, emphasis has been given recently to the development of serological assays as an aid to diagnosis. The techniques used for the serodiagnosis of serious staphylococcal infections have included gel diffusion (25, 34) , immunoelectrophoresis (11, 25) , radioimmunoassay (33, 34) , and the enzyme-linked immunosorbent assay ELISA (8, 10, 15, 36) . The most commonly used staphylococcal antigens for these assays are either ultrasonic preparations of whole cells, ribitol teichoic (TA) acid, or the peptidoglycan (PG) moiety of the cell wall. Unfortunately, differences in the preparation of antigens, as well as in the assays used for antibody detection, have generated a certain degree of variability in the data reported from laboratory to laboratory (22, 31) .
In a previous investigation, we reported on the development of an experimental staphylococcal osteomyelitis model for rabbits that closely resembles the clinical, radiographic, and histological features associated with this type of infection in humans (12) . The purpose of the present study was to evaluate the immunoglobulin G (IgG) response to S. aureus crude TA and PG in both rabbits and humans with osteomyelitis by an ELISA. Animals. New Zealand White rabbits (Dutchland Laboratories, Denver, Pa.), weighing between 3 and 4 kg each, were used. The rabbits were housed in individual cages and were maintained on a standard laboratory diet. The experiments described in this paper were conducted according to the principles set forth in the current edition of the Guide for the Care and Use of Laboratory Animals (3).
MATERIALS AND METHODS
Osteomyelitis model. The method used to create osteomyelitis has been previously described in detail (12) . Briefly, the right midfemur of each anesthetized rabbit was exposed surgically, and a duct was created in the medullary cavity with an activated high-speed drill. An 18-guage needle was used to inject 0.5 ml of a sclerosing agent (3% sodium tetradecyl sulfate; Elkins-Sinn, Cherry Hill, N. J.)-0. (20) . PG was extracted from the cell walls with 10% trichloroacetic acid at 60°C for 90 min. After centrifugation at 13,000 x g for 20 min, the supernatant was discarded and the PG pellet was washed three times with deionized water and lyophilized.
Chemical analysis of crude TA and PG. Carbohydrate determinations were performed by gas chromatography with myoinositol used as the internal standard. Samples were prepared as described by Porter (21) . Thermal decomposition of amino sugars was prevented by the avoidance of heating after the hydrolysis step. A Varian 3700 gas chromatograph equipped with CDS-111 integrated microprocessor and a 3% SP-2330 coated 100/120 Supelcoport glass column (183 cm by 2 mm) were used for the analysis. Temperatures were programmed from 170 to 210°C over 16 min.
Amino acid analysis was performed after the hydrolysis of samples with 6 Cincinnati, Ohio). This commercially available kit includes preformed agarose plates, a partially purified S. aureus (Lafferty strain) ribitol TA antigen, and a rabbit anti-ribitol TA serum. A 10-pil amount of the crude (100 ,ug/ml) or purified (30 ,ug/ml) TA preparations was added to the peripheral wells of agarose plates, and the anti-TA serum was added to the central well. After 48 h at room temperature, the plate was immersed in a 0.85% NaCI solution for 24 h, dried, and washed with several changes of deionized water.
The plate was stained with 0.5% amido black 10B (Sigma Chemical Co., St. Louis, Mo.) for 8 min and then destained overnight in a solution of glacial acetic acid, methanol, and water (1:7:2). ELISA. The microplate modification of the technique originally described by Engvall and Perlman (7) was used to detect IgG to crude TA and PG in both rabbit as well as human sera. A detailed description of the ELISA methodology has been provided elsewhere (12) . The wells of microtiter plates were coated with either crude TA (10 , ugIml) or PG (50 ,ug/ml) as determined to be optimal by a previous checkerboard titration. All sera were tested at a 1:5,000 dilution, and an alkaline phosphatase-conjugated goat antirabbit IgG or anti-human IgG (Miles Laboratories, Inc., Elkhart, Ind.) was each used at a 1:3,000 dilution. Optical density values were recorded spectrophotometrically at a wavelength of 405 nm (OD405) after a 30-min enzymesubstrate incubation period at 25°C. Sera were designated as positive for antibodies to crude TA or PG if the OD405 values exceeded the mean plus two times the standard deviation of the prebleed serum values for rabbits or the control serum values for humans.
Specificity studies. To demonstrate that the ELISA was specific for the detection of S. aureus antibodies, absorption studies were performed. Sera from five patients with S. aureus osteomyelitis were heat inactivated at 56°C for 30 min. A 5-ml amount of a 1:2,500 dilution of each serum was absorbed with an equal volume of washed S. aureus Wood 46 cells that had been adjusted spectrophotometrically to an OD540 of 0.25. The serum-cell suspensions were kept at 25°C for 4 h with intermittent agitation every 15 min and centrifuged at 8,000 x g for 20 min. The supernatants, representing the absorbed sera, were then passed through a 0.45-,umpore membrane filter to remove any residual bacteria. Both the absorbed and unabsorbed sera were tested for IgG to S. aureus crude TA by ELISA as described above.
RESULTS
Osteomyelitis model. Radiographic evidence of osteomyelitis was present in 10/13 of the rabbits whose femurs were inoculated with a combination of sclerosing agent and S. aureus. In general, radiographic changes were first noted at approximately 4 weeks postinfection and initially consisted of periosteal elevation and thickening. Because none of these animals received treatment, the osseous infection progressed in severity, and by 6 to 8 weeks increased medullary cavity density and areas of bone destruction were evident. Gross examination of the infected femurs at the time of sacrifice revealed the presence of copious amounts of purulent material within the medullary cavity, as well as extensive reactive bone formation (Fig. 1) . S. aureus was isolated from the infected femurs of 9/10 of the animals with radiographic evidence of osteomyelitis.
Chemical analysis of antigens. to the crude antigen preparation, although typical TA components such as ribose, glucosamine, and alanine were detected, there was a significant degree of contamination with other amino acids which are not present in purified preparations of TA (20) . The PG preparation, on the other hand, was relatively pure as indicated by the presence of large quantities of cell wall backbone sugars (glucosamine Table 2 shows the results of the ELISA for the detection of IgG antibodies to S. aureus WHC crude TA and PG in the sera of rabbits with osteomyelitis that were obtained throughout the 10-week experimental period. The data show that at 1 week postinfection, only 1 of 10 animals had an elevated IgG response to each antigen preparation. By 10 weeks postinfection, however, most of the animals were found to produce elevated levels of antibodies to the crude TA but three possessed increased antibody levels to PG. Of a total of 14 rabbit sera that were positive by ELISA for IgG to crude TA extracted from S. aureus WHC, 10/14 (71%) were also positive to TA of the Wood 46 strain, indicating that these antigens share common determinants. Elevated levels of IgG to either the crude TA or PG were not detected in the three animals which did not develop radiographic evidence of osteomyelitis.
Antibody response of patients with osteomyelitis. The results of the ELISA for detection of IgG to crude TA and PG of S. aureus Wood 46 in patients with osteomyelitis are shown in Table 3 . Elevated levels of IgG to the crude TA antigen were detected in 55% of the patients with acute S. aureus and in 39% of those with chronic S. aureus osteomyelitis. Of a total of 39 patients with S. aureus osteomyelitis (acute and chronic), 17 were positive for IgG to the crude TA antigen. In contrast, only 1 of 18 patients with non-S. aureus osteomyelitis was found to have an OD405 value that exceeded the established cutoff. When all of these sera were tested for IgG to S. aureus PG (Table 3) , there were virtually no differences noted in the IgG levels of the healthy controls and those of patients with osteomyelitis. The data indicate that only one patient with chronic S. aureus osteomyelitis was positive for antibodies to PG. None of the patients with either acute S. aureus or (Table 4 ). The average reduction for all sera was 86.6% and in 3/5 of the instances was greater than 90%. DISCUSSION The effective treatment of osteomyelitis requires prompt isolation and identification of the etiologic agent and appropriate selection of antimicrobial therapy. This concept was dramatically illustrated in the study by Harris (9) , who noted a 15-fold increase in the incidence of chronic osteomyelitis when treatment was delayed 3 or more days after the onset of the acute phase of the illness. Because the initial treatment is crucial for preventing the establishment of chronic osteomyelitis, the importance of obtaining bacteriological cultures cannot be overemphasized. Yet despite the most aggressive diagnostic workup, up to 40% of the cases of osteomyelitis do not produce a specific etiologic microorganism against which treatment can be directed (19) . Prompt and accurate identification of the causative agent currently requires bone biopsy for acute osteomyelitis if blood cultures are negative, as they have been reported to be in nearly 50% of cases (5, 28) . Sinus tract cultures are not reliable with less than a 50% correlation of sinus tract cultures with microorganisms recovered from bone material (14, 19) . Although bone biopsy represents the procedure of choice for establishing a correct bacterial etiology, the results of bone cultures have been reported to be negative in 10 to 31% of cases (5, 28) . In patients with osteomyelitis underlying decubitus or diabetic foot ulcers, bone biopsy is rarely indicated, because organisms colonizing the ulcers usually contaminate the biopsy specimens (32) . In addition, bone biopsy for cultures represents a specialized procedure and may occasionally require general anesthesia (14) subsequent cultures are often required to monitor for reinfection and shifts in sensitivity patterns, especially if the patient fails to show a satisfactory response (19) . Therefore, the development of a serological assay for the establishment of a bacteriological diagnosis in osteomyelitis would be extremely beneficial.
The serological diagnosis of deep-seated S. aureus infections has been the subject of intensive investigation. Whereas earlier assays measured antibodies to extracellular VOL. 25, 1987 on October 27, 2017 by guest http://jcm.asm.org/ Downloaded from S. aureus, products, notably alpha and gamma hemolysins (13, 23) , more recently the focus has shifted toward the detection of antibodies to cell-associated components, including TA (8, 10, 15, 25, 31, 36) , PG (2, 26, 27, 30, 35) , and cell walls (12) . These previous studies have shown that significantly elevated levels of antibodies to TA or PG can be detected in the vast majority of patients with complicated S. aureus bacteremia as measured by gel diffusion, ELISA, or radioimmunoassay. In contrast, it is more difficult to demonstrate an increased antibody response to these antigens in patients with S. aureus osteomyelitis, especially during the chronic phase of infection (8, 15, 25, 30, 34) .
Although there have been several clinical investigations which evaluated and compared the serologic response of patients with serious S. aureus infections to both TA and PG (2, 26, 30) (18, 20 
